“…Of these, 54 included study populations with RA and SpA [ 21 – 74 ], and 25 included study populations with seropositive and/or seronegative RA [ 75 – 99 ]. SpA-related outcomes or manifestations reported in included studies assessed by clinical examination and/or imaging comprised peripheral arthritis [ 21 – 28 , 30 – 36 , 38 – 42 , 45 – 52 , 57 – 63 , 66 , 68 , 71 , 72 , 74 – 99 ], polyarthritis [ 22 , 33 , 36 , 78 , 79 ], and oligoarthritis [ 22 , 33 ], enthesitis or enthesopathy [ 22 – 29 , 31 – 33 , 36 , 44 , 45 , 47 – 49 , 54 – 56 , 60 , 63 , 66 , 67 , 69 , 71 , 72 , 75 , 84 ], psoriasis [ 21 – 23 , 25 , 26 , 30 , 59 , 70 , 74 ], dactylitis [ 21 , 27 , 33 , 36 , 46 , 55 , 71 – 73 ], nail psoriasis [ 21 , 23 ...…”